News

Celon Pharma S.A.’s IPO was held on the main market of the Warsaw Stock Exchange on 17 October 2016. The share price on the first day of trading increased by 17.58 percent. 15,000,000 of B series ordinary shares were introduced into the regulated market of the Warsaw Stock Exchange on the basis of a prospectusRead more »

On 14 March this year another working meeting was held for the research project: “New treatment for psychotic disorders and Huntington’s disease with special focus on cognitive deficits” – NoteSzHD, with Celon Pharma S.A. as the leader. The meeting was participated in by representatives of the Nencki Institute of Experimental Biology of the Polish Academy of Sciences, theRead more »

As many as 323 students applied for an internship at Celon Pharma as part of the Win your Internship programme. Only three individuals were chosen from among all the candidates who reached the competition stage – they will carry out their internships this year, either in the company’s Research and Development Centre or the AdministrationRead more »

On 10 June 2016 ,Maciej Wieczorek, PhD, CEO of Celon Pharma S.A. presented potential ares of cooperation between young scientists and Celon Pharma’s Research and Development Centre. In a short presentation of the company, Maciej Wieczorek encouraged young people to take up research initiatives in cooperation with Polish pharmaceutical companies. Cooperation with the scientific communityRead more »

The objective of the project is to confirm the therapeutic action of the PI3K inhibitor in patients with lung diseases such as asthma or chronic obstructive pulmonary disease (COPD). The planned route of administration of the drug is inhalation. The project involves actions taken in four stages, including preclinical and toxicological studies, drug formulation, asRead more »

Leaders of research groups from the Celon Pharma S.A. Research and Development Centre provided information on current innovative projects run by the company at an exhibition stand prepared specially for the event. Additionally, on 9 May Maciej Wieczorek, PhD, CEO of Celon Pharma S.A. took part in a panel discussion which brought together guests fromRead more »

Does working in a bank teach you discipline? What was the Polish pharmaceutical sector like in the 1990s and what is the entrepreneurial ethos? Maciej Wieczorek was a guest on a show called Twarze Biznesu (The Faces of Business) hosted by Michał Broniatowski. We encourage you to watch the entire video.   http://biznes.onet.pl/wiadomosci/medycyna/twarze-biznesu-lek-na-raka-od-polskiego-milionera/drx6dj

On 9 and 10 May 2016 Celon Pharma S.A. representatives will participate in this year’s edition of BioForum, the most important event in biotechnology in Poland. This year BioForum will be held in the city of Lodz. For the fifteenth time the event will bring together representatives of business and science associated with the broadlyRead more »

The Second International Congress of Forensic Psychiatry took place on 15-16 April 2016. The “Aurelius Awards” were conferred during the event. The initiative was supported by Celon Pharma S.A. The aim of the “Aurelius Awards” is to recognise individuals who work to improve the quality of life of the mentally ill and who introduce aRead more »